Related content

Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma

By Koh Y.   Lim H. Y.   Ahn J. H.   Lee J.-L.   Rha S. Y.   Kim Y. J.   Kim T. M.   Lee S.-H.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1026-1031

Oxford University Press

Access to resources Recommend Favorite

Everolimus exhibits efficacy as a radiosensitizer in a model of non-small cell lung cancer

By              

Oncology Reports, Vol. 27, Iss. 5, 2012-01 ,pp. : 1625-1629

Spandidos Publications

Access to resources Recommend Favorite

Glycolysis in Panc-1 human pancreatic cancer cells is inhibited by everolimus

By        

Experimental and Therapeutic Medicine, Vol. 5, Iss. 1, 2013-01 ,pp. : 338-342

Spandidos Publications

Access to resources Recommend Favorite

Suppression of cytomegalovirus-specific CD8⁺T cells by everolimus

By Jin Nan   Malcherek Georg   Mani Jiju   Zurleit Romy   Schmitt Anita   Chen Baoan   Freund Mathias   Ho Anthony D.   Schmitt Michael  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1144-1150

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma

By Kim Ki   Yoon Sang   Lee Hae-Jung   Kim Hyo   Shin Sang   Ahn Joong   Rha Sun  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. : 853-860

Springer Publishing Company

Access to resources Recommend Favorite